tiprankstipranks
Advertisement
Advertisement
MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program
PremiumCompany AnnouncementsMAIA Biotechnology Highlights Progress in Phase 3 Oncology Program
1M ago
MAIA Biotechnology published a 2026 Letter to Shareholders
Premium
The Fly
MAIA Biotechnology published a 2026 Letter to Shareholders
1M ago
MAIA Biotechnology outlines 2026 goals for ateganosine program
Premium
Company Announcements
MAIA Biotechnology outlines 2026 goals for ateganosine program
2M ago
MAIA Biotechnology to sell 1.233M shares at $1.22 in private placement
PremiumThe FlyMAIA Biotechnology to sell 1.233M shares at $1.22 in private placement
4M ago
MAIA Biotechnology announces $1.51M private placement
Premium
The Fly
MAIA Biotechnology announces $1.51M private placement
4M ago
MAIA Biotechnology Announces Significant Insider Buying
Premium
Company Announcements
MAIA Biotechnology Announces Significant Insider Buying
4M ago
MAIA Biotechnology Highlights Ateganosine Progress at SITC 2025
PremiumCompany AnnouncementsMAIA Biotechnology Highlights Ateganosine Progress at SITC 2025
4M ago
MAIA Biotechnology highlights momentum of ateganosine clinical program
Premium
The Fly
MAIA Biotechnology highlights momentum of ateganosine clinical program
4M ago
MAIA Biotechnology Expands Phase 2 Study in Romania
Premium
Company Announcements
MAIA Biotechnology Expands Phase 2 Study in Romania
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100